UBS Group’s Nutraceutical International Co NUTR Stock Holding History

UBS Group’s Portfolio NUTR Stock Details NUTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,676	Closed	-$111K	–	8320
2017 Q2	$111K	Sell	2,676 -1,429	-35%	-$51K	﹤0.01%	5102
2017 Q1	$127K	Buy	4,105 +1,023	+33%	+$34.7K	﹤0.01%	4941
2016 Q4	$108K	Buy	3,082 +2,682	+671%	+$85K	﹤0.01%	5239
2016 Q3	$13K	Hold	400	–	–	﹤0.01%	6634
2016 Q2	$9K	Sell	400 -1,943	-83%	-$46.2K	﹤0.01%	6879
2016 Q1	$57K	Buy	2,343 +918	+64%	+$22.2K	﹤0.01%	5411
2015 Q4	$36K	Buy	1,425 +1,025	+256%	+$25.2K	﹤0.01%	6162
2015 Q3	$9K	Sell	400 -645	-62%	-$15.4K	﹤0.01%	7371
2015 Q2	$26K	Buy	1,045 +645	+161%	+$13.6K	﹤0.01%	6638
2015 Q1	$8K	Sell	400 -369	-48%	-$6.94K	﹤0.01%	7861
2014 Q4	$17K	Buy	+769	New	+$16.7K	﹤0.01%	7916

UBS Group's NUTR Position: Q3 2017 in Review

UBS Group sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 2,676 shares — an estimated $111K sold.

UBS Group first reported a position in NUTR in Q4 2014 and held it in 11 quarters. The position peaked at $127K in Q1 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

UBS Group reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
UBS Group sold 2,676 Nutraceutical International Co shares in Q3 2017, an estimated $111K.
UBS Group first reported a position in Nutraceutical International Co in Q4 2014 and held it in 11 quarters.
UBS Group's Nutraceutical International Co position peaked at $127K in Q1 2017.
0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.